德国拜耳利伐沙班怎么买？

(Rivaroxaban) is a drug developed and produced by Bayer in Germany. It can highly selectively and directly inhibit factor Xa, causing the coagulation cascade in the body to be blocked at the intersection of the intrinsic/extrinsic coagulation pathway, thereby inhibiting the synthesis of thrombin and prolonging PT. It is a first-line drug for the clinical prevention and treatment of deep vein thrombosis. So, how to buy Rivaroxaban from Bayer in Germany?

At present, rivaroxaban has been approved for marketing in China, and patients in need can buy the required drugs in China. In addition, patients can also contact Medical Companions to obtain rivaroxaban sold overseas. It is understood that rivaroxaban produced by Bayer in Germany has two specifications. Due to different drug specifications, its selling price is also different. Among them, a box of rivaroxaban with a specification of 20mg*28 tablets is priced at around $400, and a box of rivaroxaban with a specification of 15mg*28 tablets is priced at around $350.

After purchasing the drug, since the indications and drug specifications are different, when patients actually use Rivaroxaban (i.e. Xarelto) for treatment, they must strictly follow the doctor's instructions or use the drug according to the instructions. Otherwise, the efficacy of the drug may be reduced, and it may even lead to the occurrence of some unsafe incidents, endangering the patient's own health and life safety.

Bayer currently has 27,000 employees in the Asia-Pacific region and a sales market of 8.8 billion euros. Its relationship with the Chinese market can be traced back to the sale of dyes in 1882. Later, it established limited companies in Shanghai, Hong Kong, Tianjin, Beijing, Jiangsu and other places to carry out businesses such as medicine and health care, crop science, and material technology. By 2007, materials science and technology accounted for 72% of Bayer's sales revenue in China, medicine and health care accounted for 22%, and crop science accounted for 6%. However, with the development bottleneck in the chemical industry, Bayer shifted its development focus to medicine and health care in 2008, and its sales revenue in China accounted for 46%. It is a drug developed and produced by Bayer. The emergence of this drug has also provided a lot of help for the treatment of many patients with venous thrombosis.

Recommended hot articles: /newsDetail/86316.html